scholarly journals Autonomic nervous system activation mediates the increase in whole‐body glucose uptake in response to electroacupuncture

2017 ◽  
Vol 31 (8) ◽  
pp. 3288-3297 ◽  
Author(s):  
Anna Benrick ◽  
Milana Kokosar ◽  
Min Hu ◽  
Martin Larsson ◽  
Manuel Maliqueo ◽  
...  
Keyword(s):  
Nervous System ◽  
Autonomic Nervous System ◽  
Glucose Uptake ◽  
Whole Body ◽  
Autonomic Nervous ◽  
System Activation

Distribution of the preferred clothing pressure over the whole body

2018 ◽  
Vol 89 (11) ◽  
pp. 2187-2198 ◽  
Author(s):  
Tamaki Mitsuno ◽  
Ayaka Kai
Keyword(s):  
Nervous System ◽  
Autonomic Nervous System ◽  
Hydrostatic Pressure ◽  
Body Part ◽  
Whole Body ◽  
Elastic Band ◽  
Autonomic Nervous ◽  
Pressure Load ◽  
Calibration Methods ◽  
Clothing Pressure

A system for measuring clothing pressure employing a renewed hydrostatic pressure-balancing method was examined using three calibration methods. All methods revealed an almost perfectly linear Y = X relation for the pressure load (X) and the reading of the system (Y). In the application, the distributions of elastic band pressure were examined on 21 planes from head to foot. The preferred elastic band pressures of the leg and arm were significantly higher than those of the neck and abdomen. These results are due to the large presence of the autonomic nervous system at the surfaces of the neck and abdomen. In the area of the abdomen, the preferred elastic band pressure was higher from the mammilla to the shoulder than for the anteroposterior midlines. The development of compression ware must consider appropriate tightening for each body part.

scholarly journals Brain permeable AMPK activator R481 raises glycemia by autonomic nervous system activation and amplifies the counterregulatory response to hypoglycemia in rats

2019 ◽  
Author(s):  
Ana M. Cruz ◽  
Yasaman Malekizadeh ◽  
Julia M. Vlachaki Walker ◽  
Paul G. Weightman Potter ◽  
Katherine Pye ◽  
...  
Keyword(s):  
Nervous System ◽  
Autonomic Nervous System ◽  
Hepatic Glucose Production ◽  
Glucose Production ◽  
Ventromedial Hypothalamus ◽  
Whole Body ◽  
Ampk Activation ◽  
Autonomic Nervous ◽  
Glucose Levels

ABSTRACTAMP-activated protein kinase (AMPK) is a critical cellular and whole body energy sensor activated by energy stress, including hypoglycemia, which is frequently experienced by people with diabetes. Previous studies using direct delivery of an AMPK activator to the ventromedial hypothalamus (VMH) in rodents increased hepatic glucose production. Moreover, recurrent glucoprivation in the hypothalamus leads to blunted AMPK activation and defective hormonal responses to subsequent hypoglycemia. These data suggest that amplifying AMPK activation may prevent or reduce frequency hypoglycemia in diabetes. We used a novel brain-permeable AMPK activator, R481, which potently increased AMPK phosphorylation in vitro. R481 significantly increased peak glucose levels during glucose tolerance tests in rats, which were attenuated by treatment with AMPK inhibitor SBI-0206965 and completely abolished by blockade of the autonomic nervous system. This occurred without altering insulin sensitivity measured by hyperinsulinemic-euglycemic clamps. Endogenous insulin secretion was not altered by R481 treatment. During hyperinsulinemic-hypoglycemic clamp studies, R481 treatment reduced exogenous glucose requirements and amplified peak glucagon levels during hypoglycemia. These data demonstrate that peripheral administration of the brain permeable AMPK activator R481 amplifies the counterregulatory response to hypoglycemia in rats, which could have clinical relevance for prevention of hypoglycemia.

Abstract P129: Role of the Autonomic Nervous System in Remote Postconditioning in Humans

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Rupert P Williams ◽  
Michael I Okorie ◽  
Harminder Gill ◽  
John E Deanfield ◽  
Raymond J MacAllister ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Nervous System ◽  
Autonomic Nervous System ◽  
Whole Body ◽  
Limb Ischaemia ◽  
Protective Effects ◽  
Blood Pressure Cuff ◽  
Autonomic Nervous ◽  
Pressure Cuff ◽  
Remote Postconditioning

Brief periods of ischaemia activate systemic mechanisms that induce whole-body tolerance to subsequent prolonged and injurious ischaemia. This phenomenon, remote ischaemic preconditioning (RIPC), is sufficiently acute to reduce ischaemia-reperfusion (IR) injury even when applied simultaneously with injurious ischaemia. This aspect of RIPC is termed remote postconditioning (RPostC). We have previously demonstrated a role for the autonomic nervous system in RIPC. Using an in vivo model of endothelial IR injury, we determined if RPostC is dependent on adrenergic autonomic mechanisms. Vascular ultrasound was used to assess endothelial function in healthy volunteers by measuring dilatation of the brachial artery in response to increased blood flow during reactive hyperaemia (flow-mediated dilatation; FMD). Endothelial IR injury was induced by 20 min of upper limb ischaemia (inflation of a blood pressure cuff to 200 mm Hg) followed by reperfusion. RPostC was induced by applying 2 cycles of 5 minutes ischaemia and 5 minutes reperfusion on the leg during arm ischaemia (via a second blood pressure cuff). In order to determine the dependence of RPostC on autonomic activation, we administered the alpha adrenoceptor blocker phentolamine (0.2– 0.7mg/min, intravenously) during the application of the RPostC stimulus. FMD was determined before ischaemia and at 20 minutes of reperfusion. FMD (percentage change from baseline diameter) was compared statistically by ANOVA. IR alone caused a significant reduction in FMD (5.9±0.7% pre- versus 2.2±0.4% post-IR, n=9, P<0.001). This reduction was prevented by RPostC (5.8±0.4% pre- versus 5.4±0.3% post-IR, n=8, P>0.05). Systemic phentolamine blocked the protective effects of RPostC (FMD 6.1±0.5% pre- versus 2.0±0.3% post-IR, n=7, P<0.001). These data indicate, for the first time in humans, that protection from RPostC depends on preservation of adrenergic signalling. Alpha blockade neutralises one of the endogenous mechanisms of ischemic protection in humans; the clinical consequences of this remain to be determined.

The effect of autonomic nervous system activation on the orienting of attention in exogenous and endogenous cuing tasks

2009 ◽  
Author(s):  
Jim E. McAuliffe ◽  
Michel J. Johnson ◽  
Bruce Weaver ◽  
Miranda Deller-Quinn ◽  
Graham Scholl ◽  
...  
Keyword(s):  
Nervous System ◽  
Autonomic Nervous System ◽  
Autonomic Nervous ◽  
System Activation

Salivary a-amylase Activity-a Novel Non-Invasive Biomarker in Clinical Pathology

2018 ◽  
Vol 69 (3) ◽  
pp. 728-730
Author(s):  
Sebastian Cozma ◽  
Cristian Martu ◽  
Cristina Mihaela Ghiciuc ◽  
Francesca Romana Patacchioli ◽  
Lucia Corina Dima Cozma
Keyword(s):  
Heart Failure ◽  
Nervous System ◽  
Autonomic Nervous System ◽  
Diabetic Neuropathy ◽  
Salivary Cortisol ◽  
Amylase Activity ◽  
Clinical Pathology ◽  
Autonomic Nervous ◽  
Non Invasive ◽  
System Activation

Salivary biomarkers have developed into biological clinical research because they are accessible and easily obtained. Salivary a-amylase was proposed as an associat marker of salivary cortisol in assessing stress and at the same time as a possible non-invasive indicator of autonomic nervous system activation. Studies conducted so far have tested a-amylase activity in psychiatric disorders, diabetic neuropathy, lung disease, and autonomic nervous system activation in hypertension or heart failure.

scholarly journals Autonomic Nervous System Function in Newly Diagnosed Multiple Sclerosis: Association With Lipid Levels and Insulin Resistance

2021 ◽  
pp. 875-882
Author(s):  
M. Hardoňová ◽  
P. Šiarnik ◽  
M. Siváková ◽  
B. Suchá ◽  
M. Vlček ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Insulin Resistance ◽  
Nervous System ◽  
Autonomic Nervous System ◽  
Sympathetic Activity ◽  
Whole Body ◽  
Sensitivity Index ◽  
Positive Correlation ◽  
Autonomic Nervous ◽  
Significant Difference

Autonomic nervous system (ANS) disorders are common in multiple sclerosis (MS). Previous studies showed differences in insulin resistance (IR) and lipoprotein levels in MS subjects compared to controls. Lipolysis caused by increased sympathetic activity could be one of the possible linking mechanisms leading to dyslipidemia in MS. Our study aimed to evaluate ANS activity in the context of glucose and lipid metabolism in people with MS. We prospectively measured short-term heart rate variability (HRV), fasting lipoprotein concentrations, and calculated IR indices based on plasma glucose and insulin levels during oral glucose tolerance test (oGTT) in 32 patients with MS and 29 healthy controls matched for age, sex and body mass index in our study. There was no significant difference in HRV parameters and lipoprotein levels between MS and controls. A significant positive correlation was found between low/high-frequency power ratio (LF/HF) and triglycerides (r=0.413, p=0.021) in MS subjects but not in controls. A significantly lower whole-body insulin sensitivity index (ISIMat) was found in patients with MS compared to the control group (7.3±3.7 vs. 9.8±5.6, p=0.041). No significant correlations were found between LF/HF and IR parameters. In MS subjects, the positive correlation of LF/HF with triglycerides could reflect the effects of sympathetic activity on lipolysis. Positive correlations of sympathetic activity with increased lipoprotein levels could rather reflect processes associated with immune system activation/inflammation, than processes involved in glucose homeostasis maintenance.

Sign in / Sign up

Export Citation Format

Share Document